American Well (AMWL) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
16 Jun, 2026Opening remarks and agenda
Chair welcomed shareholders, introduced board members, and confirmed presence of auditors for the meeting.
Rules of conduct and virtual participation procedures were outlined, emphasizing accessibility and investor relations resources.
Official notice of meeting and proxy materials were confirmed as properly distributed; meeting declared properly called.
Board and executive committee updates
Roy Schoenberg resigned from the board and was not up for reelection; only Dr. Ido Schoenberg was nominated for Class III director.
Shareholder proposals
Election of one director (Dr. Ido Schoenberg) as Class III director was presented for vote.
Ratification of PricewaterhouseCoopers LLP as independent auditors for 2026 fiscal year was proposed.
Advisory vote on executive compensation as disclosed in the proxy statement was included.
Latest events from American Well
- Dr. Roy Schoenberg will not seek re-election, and no substitute director will be nominated.AMWL
Proxy filing9 Jun 2026 - Strong Q1 results and major government contracts position the company for profitable growth by 2027.AMWL
21st Annual Needham Technology, Media, & Consumer Conference14 May 2026 - Q1 2026 revenue fell 18%, but net loss narrowed and positive cash flow is targeted for Q4.AMWL
Q1 20266 May 2026 - Key votes include director elections, auditor ratification, and executive pay approval.AMWL
Proxy filing23 Apr 2026 - 2025 saw major cost reductions, platform innovation, and strong governance ahead of key shareholder votes.AMWL
Proxy filing23 Apr 2026 - 2026 guidance targets $195–$205M revenue, EBITDA breakeven, and strong government contract momentum.AMWL
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Margins improved and losses narrowed, with positive cash flow targeted for Q4 2026.AMWL
Q4 202512 Feb 2026 - Director elections, auditor ratification, and reverse stock split proposal advanced to vote.AMWL
AGM 20243 Feb 2026 - Q2 revenue rose to $62.8M, losses narrowed, and 2024 EBITDA guidance improved.AMWL
Q2 20242 Feb 2026